FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series C / Biotech startups that raised Series C in California, United States

Biotech startups that raised Series C in California, United States

Updated 16 Nov 2026

Reset
Biotech startups that raised Series C in California, United States
One-time CSV
  • 143 funded companies, 135 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-c~california-united-states.csv143 rows × 18 columns
CompanyCityLast roundAmountDate
BigHat BiosciencesSan MateoSeries C$75.0M2026-09-24
Chai DiscoverySan FranciscoSeries C$400.0M2026-07-14
CellanomeRedwood CitySeries C$75.9M2026-06-18
Terremoto BiosciencesSan FranciscoSeries C$108.0M2026-04-15
LoyalSan FranciscoSeries C$100.0M2026-02-11
Culture BiosciencesSan FranciscoSeries C$80.0M2025-12-16
Aspen NeuroscienceSan DiegoSeries C$115.0M2025-11-20
TORL BioTherapeuticsCulver CitySeries C$96.0M2025-10-07

8 rows of the CSV in 5 of its 18 columns.

143
Startups
$17.3B
Total raised
13
Funded in the last 12 months
$1.3B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

28 of 143
28 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
BigHat Biosciences BigHat Biosciences develops antibody and protein therapeutics using machine learning and automated experimentation. Artificial intelligence San Mateo Series C $75.0M 2026-09-24 $174.3M Andreessen Horowitz, Gaingels, 8VC +2 51 to 100 2019
Chai Discovery Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design. Artificial intelligence San Francisco Series C $400.0M 2026-07-14 $631.0M Thrive Capital, OpenAI 11 to 50 2024
Cellanome Cellanome uses synthetic biology and informatics methods to analyze multi-omics data. Biotech Redwood City Series C $75.9M 2026-06-18 $289.6M Premji Invest, Synetro Group 51 to 100 2020
Terremoto Biosciences Terremoto Biosciences develops medicines using lysine-based covalent chemistry. Biotech San Francisco Series C $108.0M 2026-04-15 $358.0M OrbiMed, Novo Holdings, Third Rock Ventures +2 51 to 100 2021
Loyal Loyal develops veterinary medicines to extend the healthy lifespan of senior dogs. Biotech San Francisco Series C $100.0M 2026-02-11 $237.1M Khosla Ventures, First Round Capital, Quiet Capital +1 101 to 250 2019
Culture Biosciences Culture Biosciences provides automated systems for bioprocess development of biological products. Biotech San Francisco Series C $80.0M 2025-12-16 $101.6M Y Combinator, National Science Foundation, BoxGroup +1 101 to 250 2016
Aspen Neuroscience Aspen Neuroscience is a biotechnology company that develops personalized cell therapies and autologous regenerative medicine. Biotech San Diego Series C $115.0M 2025-11-20 $387.0M Google Ventures, OrbiMed, EDBI +2 101 to 250 2018
TORL BioTherapeutics TORL BioTherapeutics is a clinical-stage biopharmaceutical company developing new therapies. Biotech Culver City Series C $96.0M 2025-10-07 $412.0M Goldman Sachs, RA Capital Management, Alexandria Venture Investments +2 51 to 100 2018
Attovia Therapeutics Attovia Therapeutics develops biotherapeutics for immune-mediated diseases. Biotech San Carlos Series C $90.0M 2025-04-15 $255.0M Goldman Sachs Asset Management, Cormorant Asset Management, Marshall Wace +2 11 to 50 2023
Biolinq Biolinq develops a wearable biosensor platform that measures blood level information. Biotech San Diego Series C $100.0M 2025-03-19 $276.3M Alpha Wave Global, Pegasus Tech Ventures, M Ventures 51 to 100 2012
ArsenalBio ArsenalBio develops programmable CAR T-cell therapies for solid tumors. Biotech South San Francisco Series C $325.0M 2024-09-04 $630.8M ARCH Venture Partners, Bristol-Myers Squibb, NVentures +1 251 to 500 2019
Autobahn Therapeutics Autobahn Therapeutics develops restorative treatments for neuropsychiatric and neuroimmunologic disorders. Biotech San Diego Series C $100.0M 2024-07-24 $208.7M Insight Partners, Invus, Bristol-Myers Squibb +2 11 to 50 2017
Bluejay Therapeutics Bluejay Therapeutics is a private biopharmaceutical company developing cures for infectious diseases. Biotech San Mateo Series C $182.0M 2024-05-09 $242.2M RA Capital Management, Wellington Management, Novo Holdings +2 11 to 50 2019
Aardvark Therapeutics Aardvark Therapeutics develops small molecule drugs for obesity and rare genetic metabolic disorders. Biotech San Diego Series C $85.0M 2024-05-09 $129.0M Cormorant Asset Management, Vickers Venture Partners, Decheng Capital +1 11 to 50 2017
Karius Karius delivers genomic insights into infectious diseases to guide clinical treatment decisions. Artificial intelligence Redwood City Series C $100.0M 2024-05-02 $354.0M Lightspeed Venture Partners, General Catalyst, Khosla Ventures +1 101 to 250 2014
Endeavor BioMedicines Endeavor BioMedicines develops treatments that target the underlying causes of pulmonary fibrosis. Biotech Solana Beach Series C $132.5M 2024-04-24 $295.5M Fidelity, Invus, T. Rowe Price +2 11 to 50 2018
Siolta Therapeutics Siolta Therapeutics develops therapeutic microbial consortia to prevent and treat inflammatory diseases. Biotech San Carlos Series C $12.0M 2024-03-12 $42.0M Khosla Ventures, Global Brain Corporation, Seventure Partners +1 1 to 10 2016
Unlearn.AI Unlearn.AI uses AI, digital twins, and statistical methods to enable smaller, more efficient clinical trials. Artificial intelligence San Francisco Series C $50.0M 2024-02-08 $134.8M Alumni Ventures, Insight Partners, 8VC +2 51 to 100 2017
Aizon Aizon provides a cloud-based SaaS platform that improves industrial processes in biotech and pharma. Artificial intelligence San Francisco Series C $20.0M 2024-02-07 $44.8M 500 Global, FundersClub, Uncork Capital +2 101 to 250 2013
Koya Medical Koya Medical develops treatments for lymphedema and venous diseases. Biotech Oakland Series C $30.0M 2023-11-15 $70.2M National Science Foundation, MedTech Innovator, OrbiMed +2 101 to 250 2018
Atomica Corp Atomica Corp operates the largest US MEMS foundry, producing photonics, sensors, and microfluidic biochips. Biotech Santa Barbara Series C $30.0M 2022-11-08 $74.4M Scale Venture Partners, Miramar Ventures, Agility Capital +1 101 to 250 2000
NovaSignal NovaSignal commercializes a robotic system for cerebral ultrasound imaging. Artificial intelligence Los Angeles Series C $37.0M 2021-09-28 $127.9M MassChallenge, National Science Foundation, TCA Venture Group +2 51 to 100 2013
InterVenn InterVenn uses artificial intelligence to study the glycoproteome for diagnostic and therapeutic healthcare solutions. Artificial intelligence South San Francisco Series C $201.0M 2021-08-02 $244.4M True Ventures, Boost VC, Anzu Partners +2 51 to 100 2017
Helix Helix is a population genomics company that advances genomics research and integrates genomic data into clinical care. Biotech San Mateo Series C $50.0M 2021-06-03 $403.0M Temasek, Warburg Pincus, Sutter Hill Ventures +1 101 to 250 2015
Insitro Unicorn Insitro applies machine learning and biology to drug discovery and development. Artificial intelligence South San Francisco Series C $400.0M 2021-03-15 $643.0M Temasek, BlackRock, ARCH Venture Partners +1 251 to 500 2018
Vineti Vineti provides a cloud-based platform that helps patients access cell and gene therapies. Biotech Oakland Series C $33.0M 2020-10-13 $115.2M S32, Casdin Capital 101 to 250 2016
Fetch Robotics Fetch Robotics provides cloud-driven autonomous mobile robots for warehouse intralogistics. Biotech San Jose Series C $46.0M 2019-07-23 $94.0M SoftBank, Shasta Ventures, Employee Stock Option Fund +2 51 to 100 2014
Pionetics Pionetics develops and manufactures drinking water purification systems. Biotech San Carlos Series C $3.0M 2007-05-21 $12.9M RockPort Capital, Pangaea Ventures, Firelake Capital Management 11 to 50 1995

Table 1. Biotech startups that raised Series C in California, United States: the 28 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 143.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Chai Discovery Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design. Artificial intelligence San Francisco Series C $400.0M 2026-07-14 $631.0M Thrive Capital, OpenAI 11 to 50 2024
2 Aspen Neuroscience Aspen Neuroscience is a biotechnology company that develops personalized cell therapies and autologous regenerative medicine. Biotech San Diego Series C $115.0M 2025-11-20 $387.0M Google Ventures, OrbiMed, EDBI +2 101 to 250 2018
3 Terremoto Biosciences Terremoto Biosciences develops medicines using lysine-based covalent chemistry. Biotech San Francisco Series C $108.0M 2026-04-15 $358.0M OrbiMed, Novo Holdings, Third Rock Ventures +2 51 to 100 2021
4 Loyal Loyal develops veterinary medicines to extend the healthy lifespan of senior dogs. Biotech San Francisco Series C $100.0M 2026-02-11 $237.1M Khosla Ventures, First Round Capital, Quiet Capital +1 101 to 250 2019
5 Culture Biosciences Culture Biosciences provides automated systems for bioprocess development of biological products. Biotech San Francisco Series C $80.0M 2025-12-16 $101.6M Y Combinator, National Science Foundation, BoxGroup +1 101 to 250 2016
6 Cellanome Cellanome uses synthetic biology and informatics methods to analyze multi-omics data. Biotech Redwood City Series C $75.9M 2026-06-18 $289.6M Premji Invest, Synetro Group 51 to 100 2020
7 BigHat Biosciences BigHat Biosciences develops antibody and protein therapeutics using machine learning and automated experimentation. Artificial intelligence San Mateo Series C $75.0M 2026-09-24 $174.3M Andreessen Horowitz, Gaingels, 8VC +2 51 to 100 2019

Table 2. Biotech startups that raised Series C in California, United States: the 7 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Khosla Ventures Venture capital firm Menlo Park, United States 6 4% 2 Prellis Biologics, Loyal
2 Bristol-Myers Squibb Venture capital firm New York, United States 5 3% 1 BigHat Biosciences
3 Y Combinator Startup accelerator Mountain View, United States 5 3% 1 Culture Biosciences
4 OrbiMed Private equity firm New York, United States 4 3% 2 Terremoto Biosciences, Aspen Neuroscience
5 RA Capital Management Startup incubator Boston, United States 4 3%
6 National Science Foundation Entrepreneurship program Alexandria, United States 3 2% 1 Culture Biosciences
7 Alexandria Venture Investments Venture capital firm Pasadena, United States 3 2% 1 Aspen Neuroscience
8 Alumni Ventures Angel group Manchester, United States 3 2%
9 8VC Venture capital firm Austin, United States 2 1% 1 BigHat Biosciences
10 Cantos Micro VC fund San Francisco, United States 2 1% 1 Prellis Biologics
11 Novo Holdings Corporate venture arm Hellerup, Denmark 2 1% 1 Terremoto Biosciences
12 EDBI Venture capital firm Singapore 2 1% 1 Aspen Neuroscience
13 S32 Venture capital firm San Diego, United States 2 1% 1 Aspen Neuroscience
14 Blue Owl Private equity firm New York, United States 2 1%
15 Cormorant Asset Management Hedge fund Boston, United States 2 1%

Table 3. Biotech startups that raised Series C in California, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 134 94% $16.2B
Software 22 15% $4.5B
Artificial intelligence 11 8% $2.8B
Hardware 8 6% $1.1B
Fintech 4 3% $543.0M
Energy 1 1% $37.4M

Table 4. Biotech startups that raised Series C in California, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series C 143 100% $35.0M

Table 5. Biotech startups that raised Series C in California, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
San Francisco 26 18%
San Diego 26 18%
Menlo Park 12 8%
South San Francisco 8 6%
San Carlos 6 4%
San Mateo 5 3%
Redwood City 5 3%
Mountain View 5 3%
Irvine 5 3%
Los Angeles 4 3%
Hayward 4 3%
Oakland 3 2%

Table 6. Biotech startups that raised Series C in California, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 8% $62.0M
September 2026 1 8% $75.0M
July 2026 2 15% $409.0M
June 2026 1 8% $75.9M
May 2026 1 8%
April 2026 1 8% $108.0M
March 2026 1 8% $22.0M
February 2026 1 8% $100.0M
January 2026 2 15% $245.0M
December 2025 1 8% $80.0M
November 2025 1 8% $115.0M

Table 7. Biotech startups that raised Series C in California, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 11 8% $1.1B
2025 11 8% $890.2M
2024 17 12% $1.3B
2023 6 4% $333.0M
2022 9 6% $922.9M
2021 10 7% $1.2B

Table 8. Biotech startups that raised Series C in California, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 2 1%
2020 to 2022 4 3%
2015 to 2019 44 31%
2010 to 2014 35 25%
Before 2010 57 40%

Table 9. Biotech startups that raised Series C in California, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 13 9%
11 to 50 69 49%
51 to 100 27 19%
101 to 250 22 16%
251 to 500 4 3%
501 to 1,000 1 1%
1,001 to 5,000 1 1%
5,001 to 10,000 1 1%
10,001 or more 2 1%

Table 10. Biotech startups that raised Series C in California, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in California, United States whose last round is Series C are on the list?
143, in the file dated 16 November 2026. 13 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 143 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series C in California, United States: 143 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in California

Other sectors that raised Series C in California

Cite: FundingWatcher, 143 biotech companies in California, United States whose most recent round is Series C, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-c/california-united-states/